https://www.dailymail.co.uk/news/article-6223117/New-cancer-vaccine-teach-immune-rogue-cells.html
Citando:
"The method involves extracting immune cells from a patient, altering them in the laboratory so they can 'see' a protein common to many cancers called HER2, and then reinjecting the cells.
Because the treatment is developed using the patient's own cells, it tends to be better tolerated and to more precisely target their cancers.
The trial was small, but for six of the patients, the experimental vaccine was cause for hope.
Tumor growth was stopped in its tracks for four patients with metastatic ovarian, gastroesophageal, prostate and bowel cancers.
Another patient's tumors shrank for more than four months, before starting to grow again.
And the vaccine worked so well in one that after nearly two years, she was still cancer-free.
Interestingly, when her cancer did come back, it no longer expressed the HER2 cells. "
